About Clonit
Founded in 1987, Clonit, an Italian biotechnology company, is focused on the development and manufacture of molecular diagnostic and in vitro diagnostic (IVD) technologies. The company applies molecular biology expertise to the design of assays and analytical systems that support the detection and monitoring of infectious diseases, genetic disorders, transplantation-related markers and oncology applications. Its portfolio is built around molecular diagnostic workflows, including real-time PCR and post-amplification analysis methods, enabling laboratories to perform sensitive nucleic acid detection, identification and characterization across a broad range of clinical and research settings.
Clonit develops diagnostic reagents, extraction technologies and instrumentation for molecular testing laboratories. Its product range includes real-time PCR assays and panels for respiratory and sexually transmitted infections, viral monitoring, inherited genetic conditions, pharmacogenetics, thrombophilia and oncogenetics, together with immunochromatographic assays and automated nucleic acid extraction solutions. The company’s CloNext® automated extraction platforms and associated reagent kits support streamlined sample preparation workflows for downstream applications including PCR, sequencing and molecular screening. Clonit products are designed to support diagnostic and translational research workflows in clinical microbiology, genetics, oncology and transplant testing.
Europa Biosite’s subsidiaries distribute for Clonit in Austria.